SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B4 - Prospectus [Rule 424(b)(4)]:
SEC Accession No. 0001104659-23-068986
Filing Date
2023-06-07
Accepted
2023-06-07 17:29:08
Documents
3

Document Format Files

Seq Description Document Type Size
1 424B4 tm2316056-9_424b4.htm 424B4 621086
2 GRAPHIC lg_transcodethera-4c.jpg GRAPHIC 43878
3 GRAPHIC fc_modular-4c.jpg GRAPHIC 211980
  Complete submission text file 0001104659-23-068986.txt   956432
Mailing Address 6 LIBERTY SQUARE #2382 BOSTON MA 02109
Business Address 6 LIBERTY SQUARE #2382 BOSTON MA 02109 857-301-6857
Transcode Therapeutics, Inc. (Filer) CIK: 0001829635 (see all company filings)

IRS No.: 811065054 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B4 | Act: 33 | File No.: 333-272082 | Film No.: 23999992
SIC: 2834 Pharmaceutical Preparations